lebrikizumab

From Aaushi

Jump to navigation Jump to search

^[1]

Contraindications

FDA denies approval for treatment of atopic dermatitis (eczema)

More general terms

pharmaceutical monoclonal antibody

References

↑ Reuters. Oct 2, 2023 U.S. FDA declines to approve Eli Lilly's drug to treat eczema https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-eli-lillys-skin-disease-drug-2023-10-02/

Retrieved from "https://aaushi.info/w/index.php?title=A58495&oldid=1185244"

↑ Back to top